Carol Sherman to Receptor Protein-Tyrosine Kinases
This is a "connection" page, showing publications Carol Sherman has written about Receptor Protein-Tyrosine Kinases.
Connection Strength
0.125
-
Alectinib salvages CNS relapses in ALK-positive lung cancer patients previously treated with crizotinib and ceritinib. J Thorac Oncol. 2015 Feb; 10(2):232-6.
Score: 0.125
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.